Cannabinoid receptor 2 mRNA 3' untranslated region (CNR2 mRNA 3'UTR)

The Cannabinoid receptor 2 (CNR2) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the CNR2 transcript that governs the expression of the CB2 receptor protein. This region contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins that influence mRNA stability, transport, and translation efficiency. In various pathological states, such as chronic inflammation and neurodegeneration, the dysregulation of miRNAs targeting the CNR2 3'UTR can lead to the downregulation of CB2 receptors, thereby exacerbating disease progression. Targeting this specific mRNA region with antisense oligonucleotides or miRNA mimics/antagomirs represents a novel therapeutic strategy to modulate CB2 receptor density and activity. By stabilizing the mRNA or preventing inhibitory miRNA binding, researchers aim to enhance the anti-inflammatory and neuroprotective effects mediated by the CB2 receptor. This approach is particularly relevant in conditions where traditional GPCR agonists may face limitations due to desensitization or lack of tissue specificity.

Other names

CB2 mRNA 3'UTRCNR2 3'-UTRCannabinoid receptor 2 3' untranslated regionCB2R mRNA 3'UTR

Modulation of protein expression through RNA interference (RNAi) or antisense-mediated degradation/blocking of the 3' untranslated region to alter mRNA stability and translation efficiency.